| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |